rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Christopher McCarthy

CFO & COO

Company insider

Files Form 4 as: CFO & COO, Interpace Biosciences.

In numbers

Trades disclosed
16
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
31 Jul 2023
Last trade
20 Aug 2026
Last filed
20 Aug 2026

Companies traded

Where they are an officer
Interpace BiosciencesOfficer · Medical Devices · last 20 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
20 Aug 2026filed 20 Aug 2026Interpace BiosciencesMedical DevicesSEC FORM 4 Code M—277,009 at $0.00filing
20 Aug 2026filed 20 Aug 2026Interpace Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—554,018 at $0.00filing
20 Aug 2026filed 20 Aug 2026Interpace Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code M—277,009 at $0.00filing
20 Aug 2026filed 20 Aug 2026Interpace Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—554,018 at $0.00filing
20 Aug 2026filed 20 Aug 2026Interpace Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code M—277,009 at $0.00filing
20 Aug 2026filed 20 Aug 2026Interpace Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—277,009 at $0.00filing
20 Aug 2026filed 20 Aug 2026Interpace Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—277,009 at $0.00filing
20 Aug 2026filed 20 Aug 2026Interpace BiosciencesMedical DevicesSEC FORM 4 Code M—277,009 at $0.00filing
1 Dec 2024filed 25 Apr 2025Interpace BiosciencesMedical DevicesSEC FORM 4 Code M—1,111 at $0.00filing
27 Jul 2024filed 25 Apr 2025Interpace BiosciencesMedical DevicesSEC FORM 4 Code M—15,112 at $0.00filing
1 Feb 2024filed 25 Apr 2025Interpace BiosciencesMedical DevicesSEC FORM 4 Code M—6,045 at $0.00filing
1 Feb 2024filed 6 Feb 2024Interpace BiosciencesMedical DevicesSEC FORM 4 Code A—10,000 at $0.00filing
31 Jan 2024filed 25 Apr 2025Interpace BiosciencesMedical DevicesSEC FORM 4 Code M—7,556 at $0.00filing
1 Dec 2023filed 25 Apr 2025Interpace BiosciencesMedical DevicesSEC FORM 4 Code M—1,095 at $0.00filing
31 Jul 2023filed 25 Apr 2025Interpace BiosciencesMedical DevicesSEC FORM 4 Code M—7,556 at $0.00filing
31 Jul 2023filed 1 Aug 2023Interpace BiosciencesMedical DevicesSEC FORM 4 Code A—25,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Vijay AggarwalDirector · Director at Interpace Biosciences, filing Form 4 there in the last year
Stephen J. SullivanDirector · Director at Interpace Biosciences, filing Form 4 there in the last year
Joseph D. KeeganDirector · Director at Interpace Biosciences, filing Form 4 there in the last year
Fortunato R. RoccaDirector · Director at Interpace Biosciences, filing Form 4 there in the last year
Thomas W. BurnellCEO, President & Chairman · CEO, President & Chairman at Interpace Biosciences, filing Form 4 there in the last year